Tag: NIH
-
Small Business Grant Supports Bone Fracture Technology
An award from National Institutes of Health is funding development of a new injected drug that promises to repair bone fractures without surgery.
-
Trial Testing Universal Nasal Spray Flu Vaccine in Children
A clinical trial is underway evaluating a vaccine given as a nasal spray among children and teens that promises to protect against multiple flu types.
-
NIH Grant Aims to Make Drugs Taste Better, Not Bitter
A new award from National Institutes of Health funds a study to identify components in taste bud cells that block bitter taste sensations encountered in some drugs and foods.
-
Clinical Trial Testing Anti-Resistant Malaria Therapy
A clinical trial is getting underway that tests the safety and dosage levels of a new drug to treat malaria and block resistance from developing to it.
-
Genomic Sequencing for Newborns Studied in Clinical Trial
A group of newborn infants with genetic disorders that went undetected in standard testing will receive genomic sequencing in a clinical study of its safety and feasibility.
-
Peptide Pain Drugs in Development Aimed at Alternative Targets
Pain drugs made from peptides, small protein-like compounds, and guided by antibodies are being developed as alternatives to prescription opioids to treat moderate to severe pain.
-
Cancer Drug Delivery Through Milk Particles Under Study
A new research project is investigating components in raw cow’s milk that could make it possible to give chemotherapy for cancer as oral drugs rather than infusions.
-
Engineered Bacteria Studied for Rare Inherited Skin Disorder
A biotechnology company and research lab are evaluating a modified skin bacteria as a treatment for Netherton syndrome, a rare inherited skin disease affecting mainly infants and young children.
-
NIH Small Business Grant Funds Severe Hepatitis Treatment
A biotechnology company is developing treatments for a severe form of hepatitis, which up to now has only limited therapy options, with a synthetic form of RNA designed to shut down the infecting virus.
-
Experimental Drug Extends Survival, Reverses Inherited ALS Damage
An experimental drug designed to silence a protein associated with inherited forms of amyotrophic lateral sclerosis, or ALS, is shown in tests with lab rodents to extend survival and reverse some neuromuscular damage.